Comment on 'Baseline patients' characteristics as predictors for therapeutic survival and response in patients with psoriasis on biological treatments'

Australas J Dermatol. 2019 Aug;60(3):e258-e259. doi: 10.1111/ajd.13016. Epub 2019 Feb 27.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Adalimumab
  • Humans
  • Psoriasis*

Substances

  • Adalimumab